To further validate independently the expression of LncRNA 17A, 51A, BACE1 and BC200 in AD plasma, these LncRNA were quantified in plasma samples obtained from a set of 88 AD patients and 72 control individuals. The gene discussed is BCYRN1; the disease is Alzheimer disease.